CoChat

Coenzyme Q10 Supplementation and Heart Failure

Singh, Uma, Devaraj, Sridevi, Jialal, Ishwarlal · 2008 · Nutrition Reviews
Cited by 103

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the Western world. Oxidative stress appears to play a pivotal role in atherosclerosis. Coenzyme Q10 (CoQ10), one of the most important antioxidants, is synthesized de novo by every cell in the body. Its biosynthesis decreases with age and its deficit in tissues is associated with degenerative changes of aging, thus implicating a possible therapeutic role of CoQl0 in human diseases. There is evidence to support the therapeutic value of CoQ10 as an adjunct to standard medical therapy in congestive heart failure. However, much further research is required, especially in the use of state-of-the-art techniques to assess functional outcomes in patients with congestive heart failure.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1753-4887.2007.tb00306.x

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 48

  1. Beyer, 1985, Tissue coenzyme Q (ubiquinone) and protein concentrations over the life span of the laboratory rat, Mech Ageing Dev, 32, 267, 10.1016/0047-6374(85)90085-5 · DOI
  2. Kalen, 1987, Ubiquinone biosynthesis by the microsomal fraction from rat liver, Biochim Biophys Acta, 926, 70, 10.1016/0304-4165(87)90183-8 · DOI · Paper page
  3. Bhagavan, 2006, Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinet-ics, Free Radic Res, 40, 445, 10.1080/10715760600617843 · DOI · Paper page
  4. Villalba, 1995, Coenzyme Q reductase from liver plasma membrane: purification and role in trans-plasma-membrane electron transport, Proc Natl Acad Sci U S A, 92, 4887, 10.1073/pnas.92.11.4887 · DOI · Paper page
  5. Alleva, 1995, The roles of coenzyme Q10 and vitamin E on the peroxidation of human low density lipoprotein subfractions, Proc Natl Acad Sci U S A, 92, 9388, 10.1073/pnas.92.20.9388 · DOI · Paper page
  6. Johansen, 1991, Coenzyme Q10, alpha-tocopherol and free cholesterol in HDL and LDL fractions, Ann Med, 23, 649, 10.3109/07853899109148098 · DOI · Paper page
  7. Aberg, 1992, Distribution and redox state of ubiquinones in rat and human tissues, Arch Biochem Biophys, 295, 230, 10.1016/0003-9861(92)90511-T · DOI · Paper page
  8. Littarru, 1972, Deficiency of coenzyme Q 10 in a succinate-CoQ Enzyme in the dystrophic rabbit on an antioxidant deficient diet, Int J Vitam Nutr Res, 42, 127
  9. Folkers, 1972, Survey and new clinical studies on conenzyme Q in human muscular dystrophy, Int J Vitam Nutr Res, 42, 139
  10. Folkers, 1985, Biochemical rationale and myocardial tissue data on the effective therapy of cardiomyopathy with coenzyme Q10, Proc Natl Acad Sci U S A, 82, 901, 10.1073/pnas.82.3.901 · DOI · Paper page
  11. Lagendijk, 1997, Ubiquinol/ubiquinone ratio as marker of oxidative stress in coronary artery disease, Res Commun Mol Pathol Pharmacol, 95, 11
  12. Kontush, 1997, Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia, Atherosclerosis, 129, 119, 10.1016/S0021-9150(96)06021-2 · DOI
  13. Hanaki, 1991, Ratio of low-density lipoprotein cholesterol to ubiquinone as a coronary risk factor, N Engl J Med, 325, 814, 10.1056/NEJM199109123251116 · DOI
  14. Hasegawa, 2005, Daily profile of plasma %CoQ10 level, a biomarker of oxidative stress in patients with diabetes manifesting postprandial hyperglycaemia, Acta Diabetol, 42, 179, 10.1007/s00592-005-0199-6 · DOI
  15. Lim, 2006, Oxidative burden in prediabetic and diabetic individuals: evidence from plasmacoenzyme Q(10), Diabet Med., 23, 1344, 10.1111/j.1464-5491.2006.01996.x · DOI
  16. Rosenfeldt, 2003, Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure, Biofactors, 18, 91, 10.1002/biof.5520180211 · DOI · Paper page
  17. Greenberg, 1990, Co-enzyme Q10: a new drug for cardiovascular disease, J Clin Pharmacol, 30, 596, 10.1002/j.1552-4604.1990.tb01862.x · DOI · Paper page
  18. Yamamura, 1967, Clinical use of coenzyme Q10 for the treatment of cardiovascular disease, Jpn Circ Jl, 31, 168
  19. Langsjoen, 1985, Effective treatment with coenzyme Q10 of patients with chronic myocardial disease, Drugs Exp Clin Res, 11, 577
  20. Langsjoen, 1997, Treatment of hypertrophic cardiomyopathy with co-enzyme Q10, Mol Aspects Med, 18, S145, 10.1016/S0098-2997(97)00006-X · doi:10.1016/s0098-2997(97)00006-x
  21. Langsjoen, 1999, Overview of the use of CoQ10 in cardiovascular disease, Biofactors, 9, 273, 10.1002/biof.5520090224 · DOI · Paper page
  22. Soja, 1997, Treatment of congestive heart failure with coenzyme Q10 illuminated by meta-analyses of clinical trials, Mol Aspects Med, 18, 159, 10.1016/S0098-2997(97)00042-3 · DOI
  23. Sander, 2006, The impact of coenzyme Q10 on systolic function in patients with chronic heart failure, J Card Fail, 12, 464, 10.1016/j.cardfail.2006.03.007 · DOI · Paper page
  24. Morisco, 1993, Effect of co-enzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study, Clin Investig, 71, 134
  25. Rengo, 1993, Role of metabolic therapy in cardiovascular disease, Clin Inves-tig, 71, 124
  26. Witte, 2005, The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure, Eur Heart J, 26, 2238, 10.1093/eurheartj/ehi442 · DOI · Paper page
  27. Jeejeebhoy, 2002, Nutritional supplementation with MyoVive repletes essential cardiac myocytes nutrients and reduces left ventricular size in patients with left ventricular dysfunction, Am Heart J, 143, 1092, 10.1067/mhj.2002.121927 · DOI
  28. Berman, 2004, Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomized, placebocontrolled study, Clin Cardiol, 27, 295, 10.1002/clc.4960270512 · DOI · Paper page
  29. Schneeberger, 1986, Biomedical and Clinical Aspects of CoenzymeQ, 5, 325
  30. Vanfraechem, 1986, Biomedical and Clinical Aspects of CoenzymeQ, 5, 371
  31. Morisco, 1994, Noninvasive evaluation of cardiac hemodynamics during exercise in patients with chronic heart failure: effects of short-term coenzyme Q10 treatment, Mol Aspects Med, 15, 155, 10.1016/0098-2997(94)90025-6 · DOI
  32. Hofman-Bang, 1995, Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure. The Q10 Study Group, J Card Fail, 1, 101, 10.1016/1071-9164(95)90011-X · DOI · Paper page
  33. Munkholm, 1999, Coenzyme Q10 treatment in serious heart failure, Biofactors, 9, 285, 10.1002/biof.5520090225 · DOI · Paper page
  34. Zhou, 1999, Effects of coenzyme Q10 on myocardial protection during cardiac valve replacement and scavenging free radical activity in vitro, J Cardiovasc Surg, 40, 355
  35. Permanetter, 1992, Ubiquinone (coenzyme Q10) in the long-term treatment of idiopathic dilated cardiomyopathy, Eur Heart J, 13, 1528, 10.1093/oxfordjournals.eurheartj.a060096 · DOI · Paper page
  36. Watson, 1999, Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure, J Am Coll Cardiol, 33, 1549, 10.1016/S0735-1097(99)00064-9 · DOI
  37. Khatta, 2000, The effect of coenzyme Q10 in patients with congestive heart failure, Ann Intern Med, 132, 636, 10.7326/0003-4819-132-8-200004180-00006 · DOI · Paper page
  38. Singh, 2003, Effect of coenzyme Q10 on risk of atherosclerosis in patients with recent myocardial infarction, Mol Cell Biochem, 246, 75, 10.1023/A:1023408031111 · DOI
  39. Elshershari, 2003, Potential usefulness of coenzyme Q10 in the treatment of idiopathic dilated cardiomyopathy in children, Int J Cardiol, 88, 101, 10.1016/S0167-5273(02)00385-6 · DOI
  40. Bargossi, 1994, Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction induced by HMG-CoA reductase inhibitors, Mol Aspects Med, 15, 187, 10.1016/0098-2997(94)90028-0 · DOI
  41. Mortensen, 1997, Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors, Mol Aspects Med, 18, 137, 10.1016/S0098-2997(97)00014-9 · DOI · Paper page
  42. Mabuchi, 2005, Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients, J Atheroscler Thromb, 12, 111, 10.5551/jat.12.111 · DOI · Paper page
  43. Bleske, 2001, The effect of pravastatin and atorvastatin on coenzyme Q10, Am Heart J, 142, E2, 10.1067/mhj.2001.116762 · DOI
  44. Stocker, 2006, Neither plasma coenzyme Q10 concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: a prospective case-control study from the LIPID study, Atherosclerosis, 187, 198, 10.1016/j.atherosclerosis.2005.09.004 · DOI
  45. Hughes, 2002, Coenzyme Q10 and differences in coronary heart disease risk in Asian Indians and Chinese, Free Radic Biol Med, 32, 132, 10.1016/S0891-5849(01)00783-3 · DOI
  46. Heck, 2000, Potential interactions between alternative therapies and warfarin, Am J Health Syst Pharm, 57, 1221, 10.1093/ajhp/57.13.1221 · DOI · Paper page
  47. Bonakdar, 2005, Coenzyme Q10, Am Fam Physician, 72, 1065
  48. Vogel, 2005, Task Force on Clinical Expert Consensus Documents (Writing Committee to Develop an Expert Consensus Document on Complementary and Integrative Medicine), J Am Coll Cardiol, 46, 184, 10.1016/j.jacc.2005.05.031 · DOI

Cited by

See all 103

Metadata

Authors
Singh, U., Devaraj, S., & Jialal, I.
Venue
Nutrition Reviews
Published
2008-06-28
Volume
65
Issue
6
Pages
286-293
ISSN
0029-6643 (ISSN-L)
OpenAlex
W2124841434
Cited by
103
References
6
FWCI
1.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Coenzyme Q10 Supplementation and Heart Failure. https://app.cochat.ai/papers/10.1111/j.1753-4887.2007.tb00306.x
The paper
Singh, U., Devaraj, S., & Jialal, I. (2008). Coenzyme Q10 Supplementation and Heart Failure. Nutrition Reviews. https://doi.org/10.1111/j.1753-4887.2007.tb00306.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.